The role of simulated-experience and descriptive formats on perceiving risks of strong opioids: A randomized controlled trial with chronic noncancer pain patients.

Chronic noncancer pain Description–experience gap Drug safety Risk communication Risk perception Strong opioids

Journal

Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280

Informations de publication

Date de publication:
06 2022
Historique:
received: 05 02 2021
revised: 30 08 2021
accepted: 04 10 2021
pubmed: 27 10 2021
medline: 1 6 2022
entrez: 26 10 2021
Statut: ppublish

Résumé

Opioid prescription rates worldwide suggest miscalibrated risk perceptions among those who prescribe, dispense, and take opioids. Findings from cognitive science show that risk perceptions can differ systematically depending on whether people learn about risks by description or experience. We investigated the effects of descriptive and simulated experience risk formats on patients' risk perceptions and behavior regarding long-term strong opioid use. 300 German patients with chronic noncancer pain were randomly assigned in an exploratory randomized controlled trial to either a descriptive format (fact box) or a simulated experience format (interactive simulation). Primary endpoints were subjective and objective risk perceptions and intended intake behavior. Both formats significantly improved patients' objective risk perception; patients who saw the fact box estimated some outcomes more accurately (p = .031). Formats were equally effective in improving patients' subjective risk perception in terms of opioids' harms; however, patients receiving the simulation showed a greater reduction and termination of their opioid intake (p = .030) and a higher uptake of alternative therapies. Descriptive and simulated experience risk formats improve risk perceptions and behavior regarding potent but highly risky drugs. To eliminate risky behavior, simulated experience formats may be superior to descriptive formats.

Identifiants

pubmed: 34696941
pii: S0738-3991(21)00658-3
doi: 10.1016/j.pec.2021.10.002
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1571-1580

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Odette Wegwarth (O)

Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany; Institute for Medical Sociology & Rehabilitation Science, Charité - University Hospital Berlin, Berlin, Germany; Center for Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Germany. Electronic address: wegwarth@mpib-berlin.mpg.de.

Wolf-Dieter Ludwig (WD)

Drug Commission of the German Medical Association, Berlin, Germany.

Claudia Spies (C)

Center for Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Germany.

Erika Schulte (E)

Center for Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Germany.

Ralph Hertwig (R)

Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH